Jubilant Pharmova Ltd - 530019 - Audited Financial Results For March 31, 2024
Audited Financial Results for March 31, 202429-05-2024
29-05-2024
Jubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting29-05-2024
Jubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting29-05-2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Advertisement for Postal Ballot28-05-2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201528-05-2024
Jubilant Pharmova Ltd - 530019 - Corporate Action-Board to consider Dividend
Intimation for recommendation of Final Dividend, if any.22-05-2024
Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Intimation Of Board Meeting And Recommendation Of Final Dividend, If Any.
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Intimation of Board Meeting and recommendation of Final Dividend, if any.22-05-2024
Jubilant Pharmova Ltd - 530019 - Announcement - Appointment Of Mr. Harsher Singh As CEO Of Radiopharma Business
Announcement - Appointment of Mr. Harsher Singh as CEO of Radiopharma Business02-05-2024
Jubilant Pharmova Ltd - 530019 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201530-04-2024